Catalyst OrthoScience, a Naples, FL-based private medical technology company, raised $20M in equity and venture debt financing.
Backers included RC Capital, Mutual Capital Partners and Bridge Bank.
The company intends to use the funds to expand its distribution channel, further invest in talent and training, launch new products, and solidify its position as a leading innovator.
Founded in 2014 by Steven Goldberg, and led by Carl O’Connell, CEO, Catalyst OrthoScience provides systems that offer precision and accuracy in shoulder restoration while preserving the patient’s bone and soft tissue.
The company, which also announced it has surpassed 10,000 total shoulder arthroplasty (TSA) procedures, has a growing portfolio of patents and pending patents on its distinctive offerings, which are available across the U.S.
